98%
921
2 minutes
20
Background: The TG-51 protocol describes methods for obtaining reference dosimetry measurements for external photon and electron beams. Since the publication of TG-51 in 1999, research on reference dosimetry has allowed revisiting the procedures and data recommended in the protocol. An Addendum to TG-51 for electron beam reference dosimetry was published in 2024, which revises the formalism and procedures and provides updated data.
Purpose: To compare clinical reference dosimetry measurements in electron beams obtained using the original American Association of Physicists in Medicine's (AAPM) TG-51 protocol and its associated Addendum (AAPM WGTG51 report 385).
Methods: Measurements were performed in electron beams using the data and methods prescribed by TG-51 and its Addendum. Nine participants (eight clinics and one primary standards laboratory) provided data and measurements. Results were obtained with 18 linacs using 87 total beam energies (4-6 energies per linac) between 4-22 MeV, representing the range of electron beam energies used clinically. Various cylindrical (6 types) and parallel-plate (4 types) ionization chamber types were employed, representing most of the chambers commonly used in modern radiation therapy clinics. An analysis was performed to determine if differences arise from the new data recommended for beam quality conversion factors or from changes to the procedure.
Results: Results for dose to water per monitor unit obtained using the Addendum are up to 2.3% higher in low-energy beams and 1.3% higher in high-energy beams compared to results obtained using the original TG-51 protocol. These differences are consistent with what was predicted by the Addendum. Differences arise from both the changes to procedure (up to 0.7% from not requiring the correction for cylindrical chambers, 0.5% from the change in the shift of the point of measurement for parallel-plate chambers) as well as the recommended data (0.8% from differences in , 0.5% from differences in ).
Conclusion: This work elucidates where differences arise in results obtained using the original TG-51 protocol and its associated Addendum for electron beam reference dosimetry. The results presented here provide confidence in the new approach and data recommended by the Addendum. Clinical physicists can use these results to ensure that differences are as expected when implementing the Addendum.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12149709 | PMC |
http://dx.doi.org/10.1002/mp.17802 | DOI Listing |
Med Phys
September 2025
Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
Background: Radiotherapy workflows conventionally deliver one treatment plan multiple times throughout the treatment course. Non-coplanar techniques with beam angle optimization or dosimetrically optimized pathfinding (DOP) exploit additional degrees of freedom to improve spatial conformality of the dose distribution compared to widely used techniques like volumetric-modulated arc therapy (VMAT). The temporal dimension of dose delivery can be exploited using multiple plans (sub-plans) within one treatment course.
View Article and Find Full Text PDFEnviron Geochem Health
September 2025
Environmental Hydrology Division, National Institute of Hydrology, Roorkee, 247667, India.
Radon (Rn) is a naturally occurring radioactive gas produced by the decay of uranium-bearing minerals in rocks and soils. Long-term exposure to elevated radon levels in drinking water is associated with an increased risk of stomach and lung cancers. This study aims to assess the concentration of radon in groundwater and evaluate its potential health risks in six cancer-affected districts, i.
View Article and Find Full Text PDFJ Nucl Med Technol
September 2025
Anatomy and Imaging Department, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil; and.
Diagnostic reference levels (DRLs) are essential for optimizing radiologic practices and ensuring patient safety. This study aimed to establish typical DRLs for nuclear medicine (NM) procedures performed at a Brazilian public university hospital. A retrospective analysis of 2,609 patient records from 13 routine NM procedures was conducted.
View Article and Find Full Text PDFEur J Nucl Med Mol Imaging
September 2025
Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
Purpose: Cardiac noradrenergic denervation visualized by meta-[I]iodobenzylguanidine ([I]MIBG) imaging supports the diagnosis of Parkinson's disease (PD). Recently, meta-[F] fluorobenzylguanidine ([F]MFBG) PET demonstrated favorable imaging characteristics compared with [I]MIBG scintigraphy for neuroendocrine tumors. We assessed [F]MFBG dosimetry and myocardial pharmacokinetics in healthy controls and PD patients.
View Article and Find Full Text PDFJ Cancer Res Clin Oncol
September 2025
Cancer Treatment and Nuclear Cardiology Department, Al Azhar University, Cairo, Egypt.
Background: High-dose-rate (HDR) brachytherapy is essential in the treatment of locally advanced cervical cancer. While Iridium-192 (Ir-192) is commonly used, its short half-life imposes logistical and financial constraints, particularly in low- and middle-income countries (LMICs). Cobalt-60 (Co-60), with a longer half-life and lower operational costs, is a viable alternative.
View Article and Find Full Text PDF